Blake Middleton, DO
Sports Medicine · Oklahoma City, OKNPI 1568703700
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Pylant Medical at 32.9% of the total. Reporting peaked in 2023 at $857 and has fallen 63.4% since, to $314 in 2025.
Across 34 payments — averaging $82.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$927
- Pacira Pharmaceuticals Incorporated$789
- Arthrex$278
- Tenex Health Inc.$195
- Trice Medical, Inc.$184
- Stryker$174
- plus $275 from 8 others
What the payments were for
- Travel & lodging$73426%
- Food & beverage$1,34648%
- Education$74126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 5 | $927 |
| Pacira Pharmaceuticals Incorporated | 11 | $789 |
| Arthrex | 4 | $278 |
| Tenex Health Inc. | 1 | $195 |
| Trice Medical, Inc. | 1 | $184 |
| Stryker | 1 | $174 |
| Boston Scientific | 1 | $126 |
| Bioventus LLC | 2 | $31 |
| AbbVie | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Amgen | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Sobi, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,822 in reported general payments places this provider in the 70th percentile of 55 sports medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 19 | $2,206 |
| Duloxetine Hcl | 78 | $1,291 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 12 | $967 |
| Gabapentin | 82 | $913 |
| Pregabalin | 43 | $707 |
| Diclofenac Sodium | 58 | $680 |
| Meloxicam | 156 | $507 |
| Rosuvastatin Calcium | 15 | $398 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $337 |
| Tizanidine Hcl | 39 | $284 |
| Tramadol Hcl | 55 | $189 |
| Celecoxib | 14 | $173 |
| Methylprednisolone | 13 | $106 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Oklahoma City
- Michael MaxtedOklahoma City$23K
- George GhataOklahoma City$7K
- Douglas RowlesOklahoma City$6K
- Charles PasqueOklahoma City$3K
- Timothy GeibOklahoma City$2K
- Seethal MadhavarapuOklahoma City$480
- Gene MuseOklahoma City$348
- Anthony CruseOklahoma City$213
- Antoine JabbourTulsa$55K
- John GlomsetNorman$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.